Results 1 to 10 of about 65,267 (260)
Pancreatic Ductal Adenocarcinoma [PDF]
Mayo Clinic Proceedings, 2017 Pancreatic ductal adenocarcinoma is ranked fourth in cancer-causing deaths. Most cases of pancreatic cancer are advanced and unresectable at the time of diagnosis due to their delayed symptomatic presentation. PET/MR imaging has a high sensitivity and specificity for detecting malignant pancreatic lesions and provides superior soft tissue detail to ...
+5 more sources
Ductal Pancreatic Adenocarcinoma [PDF]
Deutsches Ärzteblatt international, 2014 Ductal adenocarcinoma of the pancreas is the fourth most common cause of death from cancer in men and women in Germany: about 15 000 persons die of this disease each year.The S3 guideline on exocrine pancreatic carcinoma was updated with the aid of systematic literature reviews on the surgical, neoadjuvant, and adjuvant treatment of ductal pancreatic ...
Seufferlein, Thomas +5 more
openaire +2 more sources
Pancreatic Ductal Adenocarcinoma [PDF]
, 2020 The most frequent indication for pancreatic fine-needle aspiration sampling is to confirm or exclude a pancreatic ductal adenocarcinoma (PDAC). PDAC is the most common malignant neoplasm of the pancreas, and the term pancreatic cancer typically connotes this entity.
Jasreman, Dhillon, Michel, Betancourt
openaire +3 more sources
Pancreatic ductal adenocarcinoma staging [PDF]
Cancer Imaging, 2013 In addition to clinical history and evaluations, the results of laboratory tests and imaging studies help clinicians in determining treatment strategies. Imaging plays a central role in the management of oncology patients including the initial diagnosis, staging, and follow-up to assess treatment response. Historically, radiologists have relied on free-
Al-Hawary, Mahmoud M., Francis, Isaac R.
openaire +2 more sources
Familial Pancreatic Ductal Adenocarcinoma [PDF]
The American Journal of Pathology, 2019 Pancreatic ductal adenocarcinoma (PDAC), although a rare disease, has a poor prognosis. With 5-year overall survival of 8%, there is a critical need to detect PDAC early or at a premalignant stage. Current screening methods are largely imaging based, but a more focused screening approach based on modifiable and nonmodifiable risk factors may improve ...
Kelly E, Diaz, Aimee L, Lucas
openaire +2 more sources
Syndecans and Pancreatic Ductal Adenocarcinoma [PDF]
Biomolecules, 2021 Pancreatic Ductal Adenocarcinoma (PDAC) is a fatal disease with poor prognosis because patients rarely express symptoms in initial stages, which prevents early detection and diagnosis. Syndecans, a subfamily of proteoglycans, are involved in many physiological processes including cell proliferation, adhesion, and migration.
Betriu, Nausika +4 more
openaire +4 more sources
Models of pancreatic ductal adenocarcinoma [PDF]
Cancer and Metastasis Reviews, 2021 AbstractAlthough pancreatic cancer remains to be a leading cause of cancer-related deaths in many industrialized countries, there have been major advances in research over the past two decades that provided a detailed insight into the molecular and developmental processes that govern the genesis of this highly malignant tumor type.
Rayane Dennaoui +2 more
openaire +2 more sources
[Pancreatic ductal adenocarcinoma]. [PDF]
Der Internist, 2019 Pancreatic ductal adenocarcinoma represents the most common malignant tumor of the pancreas. Despite substantial research efforts and gradual diagnostic and therapeutic improvements, its prognosis remains dismal. In accordance with the current German, European, and US guidelines, this CME-article provides a comprehensive review of the disease.
E, Gallmeier, T M, Gress
openaire +3 more sources
Targeting Pancreatic Ductal Adenocarcinoma (PDAC) [PDF]
Cellular Physiology and Biochemistry, 2020 Pancreatic cancers are among the most ominous, and among the most studied. Their complexities have provided ample material for a huge investigative effort, which is briefly surveyed in this review. Eradication by surgery has proven extremely difficult, and a successful chemotherapeutic approach is desperately needed.
Sofia Parrasia +6 more
openaire +5 more sources
Mimics of pancreatic ductal adenocarcinoma [PDF]
Cancer Imaging, 2013 Several uncommon primary pancreatic tumors, inflammatory conditions, metastasis to the pancreas and peripancreatic masses can mimic the appearance of pancreatic ductal adenocarcinoma (PDA). Differentiation between these lesions and PDA can be challenging, due to the overlap in imaging features; however, familiarity with their typical imaging features ...
Al-Hawary, Mahmoud M. +4 more
openaire +2 more sources